ScoutRx?的动态

Some great arguments for and against Preferred Provider (Pharmacy) Networks (PPNs) in this article. While I understand why there are concerns regarding PPNs, I feel like the benefits of having one - especially for higher cost specialty drugs - outweigh any perceived downfalls. My perspective is heavily biased towards overall cost containment however...what are your thoughts?

3 things that stand out in this article: 1. Direct to Consumer pharmacy is a credible competitor in this space 2. They are not comparing apples to apples - total cost of drugs! 3. Mark Cuban’s pharmacy is making a dent in the market. Mark Cuban Cost Plus Drug Company, PBC Your thoughts? #innovatormd #founderinstitite #costplusdrugs #pharmacycosts

This was an interesting article and I would love to hear from my other colleagues on the subject. Although I understand the intentions are to lower drug costs, I believe you have to start at the root and that is not the PBM’s. My take on this is; a PBM‘s role is to put their clients in the best position to control pharmacy spending. Their role is: Processing prescription drug claims Maintaining a pharmacy network Managing formularies Providing mail order services Setting up rebate payments to pharmacies Managing drug use I’m not saying that PBM’s are above reform, as all aspects of how we manage our healthcare system need to be reformed. However, it is the pharmaceutical wholesalers that need to be put under a microscope. There are 3 that control 90% of the market. They set the price of the drugs. To fix the problem, you have to get the root and it starts with the wholesalers. Let me know your reactions.

The big three PBMs (represent 80% of the patients whose prescriptions are covered by insurance) negotiate huge, non-transparent rebates and discounts from their manufacturers in exchange for covering them on behalf of the millions of patients they represent. Drug rebates and list prices are positively correlated: On average, a $1 increase in rebates is associated with a $1.17 increase in list price. #Transparentdrugpricing #pricing

Many employers are evaluating their health insurance plans right now and they're facing the hidden cost burden of skyrocketing #PrescriptionDrugs prices. ?? So, what can businesses do to mitigate the impact of rising prescription costs? ?? Work with a broker who can negotiate effective, client-aligned contracts. ? Implement independent prior authorization reviews. ?? Laser focus on GLP-1 and specialty cost containment. ?? Leverage data analytics for smart plan design and strong clinical management. ?? Bolt on a pharmacy cost containment solution, like SHARx, LLC to access quality specialty prescriptions drugs at the lowest possible price. ?? Secure exceptional service for patients and members. By taking proactive steps, businesses and organizations can mitigate the impact of rising prescription costs and protect their bottom line. Let's discuss this critical issue further. Share your thoughts and experiences in the comments below! ?? #PrescriptionPriceHikes #BusinessImpact #HealthcareCosts #EmployeeWellness #AffordableHealthcare

If you have a non-calendar year plan and you change carriers’ mid-year, list the carrier that you have at the beginning of the calendar year first, then put a semicolon in and put the second carrier. #compliance #pharma #pharmaceutical #insurance #insuranceindustry #employers #rx #rxdc

51% of Americans with insurance say they can't predict how much their covered prescription drugs will cost. This can lead to serious financial disruption resulting in millions of prescriptions left at the pharmacy counter. Employers can provide stability through benefits design by offering tools that support employees in managing prescription costs. Read more: https://bit.ly/4eeyQyF

Important read!

PBMs are scum of the earth. You don't like brokers in truck driving? Wait till you learn why things like Ozempic are so expensive... PBMs. PBMs, the middleman who will delist a cheaper drug (or attempts to lower the cost of a drug) from insurance formularies just because they can make more money off a percentage of it if it is a more expensive drug. They practically force pharmaceutical companies to charge a higher price for medicine to keep it listed. For a long time PBMs have had unmitigated power to make healthcare costs higher for the average American, and have even choked the profits of pharmaceutical manufacturers. They manipulate the market at the expense of sick Americans.

Did you know that the average American takes 4 prescription medications? The number of older adults taking prescription medication is even greater. Prescription drug plans are the biggest driver of cost increases to insurance programs. However, we have life-changing drugs that lead to better outcomes and improve quality of life. Human Resource leadership and benefits teams have new options to address rising costs. As a consumer, paying attention to the drugs you take is crucial. Specialty and brand-name drugs are the biggest cost drivers. Reach out to discuss how I can help you or your business plan for these costs and leverage new strategies to control increases in your future renewals. #prescriptiondrugplans #controlcosts #betterconsumerswin